nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adolescent characteristics and incidence of pre-malignant disease and invasive tumors of the cervix
|
Keinan Boker, Lital |
|
|
30 |
7 |
p. 959-968 |
artikel |
2 |
African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type
|
Whitmore, Gabrielle |
|
|
30 |
7 |
p. 1018-1025 |
artikel |
3 |
A guide to poly ADP-ribose polymerase inhibitor (PARPi) toxicity management
|
Patel, Shrina Divyesh |
|
|
30 |
7 |
p. 916 |
artikel |
4 |
A seven-step surgical strategy for robotic splenectomy
|
Katebi Kashi, Payam |
|
|
30 |
7 |
p. 1079-1080 |
artikel |
5 |
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study
|
Klapdor, Rudiger |
|
|
30 |
7 |
p. 920-926 |
artikel |
6 |
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study
|
Mayadev, Jyoti |
|
|
30 |
7 |
p. 1065-1070 |
artikel |
7 |
Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2–3
|
Gonzalez-Bosquet, Eduardo |
|
|
30 |
7 |
p. 954-958 |
artikel |
8 |
β-catenin and PD-L1 expression in mismatch repair deficient endometrial carcinomas
|
Rowe, Margaret |
|
|
30 |
7 |
p. 993-999 |
artikel |
9 |
Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002)
|
Altin, Duygu |
|
|
30 |
7 |
p. 1005-1011 |
artikel |
10 |
Correction: Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer
|
|
|
|
30 |
7 |
p. 1084 |
artikel |
11 |
Correction: Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer
|
|
|
|
30 |
7 |
p. 1087 |
artikel |
12 |
Correction: Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis
|
|
|
|
30 |
7 |
p. 1085-1086 |
artikel |
13 |
Expression of immune cell markers and tumor markers in patients with cervical cancer
|
Zhang, Liming |
|
|
30 |
7 |
p. 969-974 |
artikel |
14 |
Frontline fighters: the continued fight against COVID-19
|
Akilli, Huseyin |
|
|
30 |
7 |
p. 1077-1078 |
artikel |
15 |
Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer
|
Høgdall, Estrid |
|
|
30 |
7 |
p. 1034-1042 |
artikel |
16 |
Laparoscopic Boari flap formation in advanced ovarian carcinoma
|
Daly, Niamh |
|
|
30 |
7 |
p. 1081 |
artikel |
17 |
Letrozole in the management of advanced ovarian cancer: an old drug as a new targeted therapy
|
Marchetti, Claudia |
|
|
30 |
7 |
p. 1058-1064 |
artikel |
18 |
Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events
|
Madariaga, Ainhoa |
|
|
30 |
7 |
p. 903-915 |
artikel |
19 |
Molecular and biological profile may discriminate between synchronous or metachronous endometrial and ovarian cancer
|
Iacobelli, Valentina |
|
|
30 |
7 |
p. 1071-1076 |
artikel |
20 |
Multidisciplinary personalized approach in the management of vulvar cancer – the Vul.Can Team experience
|
Tagliaferri, Luca |
|
|
30 |
7 |
p. 932-938 |
artikel |
21 |
Multimodality adjuvant therapy and survival outcomes in stage I–IV uterine carcinosarcoma
|
McEachron, Jennifer |
|
|
30 |
7 |
p. 1012-1017 |
artikel |
22 |
Palliative electrochemotherapy in primary or recurrent vulvar cancer
|
Corrado, Giacomo |
|
|
30 |
7 |
p. 927-931 |
artikel |
23 |
Palliative treatment with electrochemotherapy in recurrent or metastatic vaginal cancer
|
Perrone, Anna Myriam |
|
|
30 |
7 |
p. 939-946 |
artikel |
24 |
Patient-initiated follow-up for low-risk endometrial cancer: a cost-analysis evaluation
|
Luqman, Iqra |
|
|
30 |
7 |
p. 1000-1004 |
artikel |
25 |
Patterns of recurrence after laparoscopic versus open abdominal radical hysterectomy in patients with cervical cancer: a propensity-matched analysis
|
Bogani, Giorgio |
|
|
30 |
7 |
p. 987-992 |
artikel |
26 |
Perineal resection and anorectal amputation with perforator flap reconstruction by a dorsal approach in prone Jackknife position
|
Martínez-Gómez, Carlos |
|
|
30 |
7 |
p. 1082-1083 |
artikel |
27 |
Post-operative pancreatic fistula following splenectomy with or without distal pancreatectomy at cytoreductive surgery in advanced ovarian cancer
|
Bizzarri, Nicolò |
|
|
30 |
7 |
p. 1043-1051 |
artikel |
28 |
Radiologic Assessment of Groin Lymph Nodes in Pelvic Malignancies
|
Rudra, Soumon |
|
|
30 |
7 |
p. 947-953 |
artikel |
29 |
Radiotherapy in Southern Italy at the time of COVID-19: options for radiation oncology units
|
Pezzulla, Donato |
|
|
30 |
7 |
p. 917-919 |
artikel |
30 |
Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors
|
Lord, Rosemary |
|
|
30 |
7 |
p. 1026-1033 |
artikel |
31 |
Simple vaginal trachelectomy in women with early-stage low-risk cervical cancer who wish to preserve fertility: the new standard of care?
|
Plante, Marie |
|
|
30 |
7 |
p. 981-986 |
artikel |
32 |
The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy
|
Hwang, Woo Yeon |
|
|
30 |
7 |
p. 975-980 |
artikel |
33 |
Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer
|
Li, Sue |
|
|
30 |
7 |
p. 1052-1057 |
artikel |